|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0010592,
umls-concept:C0022646,
umls-concept:C0022671,
umls-concept:C0036043,
umls-concept:C0205360,
umls-concept:C0376387,
umls-concept:C0439231,
umls-concept:C0684224,
umls-concept:C0699605,
umls-concept:C1257890,
umls-concept:C1522577,
umls-concept:C1577018,
umls-concept:C2603343
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1998-3-24
|
|
pubmed:abstractText |
There has been concern that the increased drug exposure associated with treatment with cyclosporine microemulsion (CsA-ME) would lead to an increase in adverse events.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
pubmed-author:BelitskyPP,
pubmed-author:BoucherAA,
pubmed-author:ColeEE,
pubmed-author:DalozePP,
pubmed-author:DandavinoRR,
pubmed-author:HalloranPP,
pubmed-author:HandaPP,
pubmed-author:HendricksLL,
pubmed-author:JeffreyJJ,
pubmed-author:KeownPP,
pubmed-author:LandsbergDD,
pubmed-author:LawenJJ,
pubmed-author:LoertscherRR,
pubmed-author:MuirheadNN,
pubmed-author:ParfreyPP,
pubmed-author:PaulLL,
pubmed-author:RushDD,
pubmed-author:RussellDD,
pubmed-author:ShokerAA,
pubmed-author:StillerCC,
pubmed-author:TarEE,
pubmed-author:ZaltzmanJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
505-10
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9500624-Administration, Oral,
pubmed-meshheading:9500624-Adult,
pubmed-meshheading:9500624-Blood Pressure,
pubmed-meshheading:9500624-Canada,
pubmed-meshheading:9500624-Communicable Diseases,
pubmed-meshheading:9500624-Cyclosporine,
pubmed-meshheading:9500624-Emulsions,
pubmed-meshheading:9500624-Female,
pubmed-meshheading:9500624-Follow-Up Studies,
pubmed-meshheading:9500624-Humans,
pubmed-meshheading:9500624-Kidney Transplantation,
pubmed-meshheading:9500624-Living Donors,
pubmed-meshheading:9500624-Male,
pubmed-meshheading:9500624-Middle Aged,
pubmed-meshheading:9500624-Neoplasms,
pubmed-meshheading:9500624-Postoperative Complications,
pubmed-meshheading:9500624-Prospective Studies,
pubmed-meshheading:9500624-Time Factors,
pubmed-meshheading:9500624-Tissue Donors
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study Group.
|
|
pubmed:affiliation |
University of British Columbia and the BC Transplant Society, Vancouver, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
